Skip to main content
. Author manuscript; available in PMC: 2015 Jan 15.
Published in final edited form as: Clin Cancer Res. 2013 Nov 11;20(2):331–343. doi: 10.1158/1078-0432.CCR-13-1736

Fig. 3. Specific CD8+ TIL clone lysis of autologous gastric and a bile duct cancer cell lines.

Fig. 3

Chromium 51-release assays testing cancer cell line lysis by the TRBV6-1 and TRBV9 CD8+ TIL clones from patient 3, and TRBV28 and TRBV3-1 clones from patient 5 in different experiments. (A) Patient 3 TRBV9 CD8+ TIL clone lysed autologous GALMa and GALMc, whereas the TRBV6-1 sister CD8+ clones only lysed autologous GALMa and GALMd (in B). (B) From patient 5, TRBV28 and TRBV3-1 CD8+ TIL clones lysed two autologous cancer cell lines (BAOMa and BAAM). For all clones, reactivity was specific to autologous tumor cell lines.